A collagen glucosyltransferase drives lung adenocarcinoma progression in mice

[1]  Luca Gasperini,et al.  The stiffness of living tissues and its implications for tissue engineering , 2020, Nature Reviews Materials.

[2]  Huanming Yang,et al.  An Integrated Gene Expression Landscape Profiling Approach to Identify Lung Tumor Endothelial Cell Heterogeneity and Angiogenic Candidates. , 2020, Cancer cell.

[3]  Philippe M. Campeau,et al.  Bruck syndrome 2 variant lacking congenital contractures and involving a novel compound heterozygous PLOD2 mutation. , 2020, Bone.

[4]  M. Yamauchi,et al.  Role of Glycosyltransferase 25 domain 1 in Type I Collagen Glycosylation and Molecular Phenotypes. , 2019, Biochemistry.

[5]  J. Uitto,et al.  Mutations in PLOD3, encoding lysyl hydroxylase 3, cause a complex connective tissue disorder including recessive dystrophic epidermolysis bullosa-like blistering phenotype with abnormal anchoring fibrils and type VII collagen deficiency. , 2019, Matrix biology : journal of the International Society for Matrix Biology.

[6]  F. Forneris,et al.  SiMPLOD, a Structure‐Integrated Database of Collagen Lysyl Hydroxylase (LH/PLOD) Enzyme Variants , 2019, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[7]  V. Olieric,et al.  Molecular architecture of the multifunctional collagen lysyl hydroxylase and glycosyltransferase LH3 , 2018, Nature Communications.

[8]  Torsten Schwede,et al.  SWISS-MODEL: homology modelling of protein structures and complexes , 2018, Nucleic Acids Res..

[9]  Mitchell D. Miller,et al.  Pro-metastatic collagen lysyl hydroxylase dimer assemblies stabilized by Fe2+-binding , 2018, Nature Communications.

[10]  Hong Jiang,et al.  Tumor-associated fibrosis as a regulator of tumor immunity and response to immunotherapy , 2017, Cancer Immunology, Immunotherapy.

[11]  G. Phillips,et al.  A scalable lysyl hydroxylase 2 expression system and luciferase-based enzymatic activity assay. , 2017, Archives of biochemistry and biophysics.

[12]  M. Girolami,et al.  Regulation of post-Golgi LH3 trafficking is essential for collagen homeostasis , 2016, Nature Communications.

[13]  H. Hamazaki,et al.  Catalytic site of human protein-glucosylgalactosylhydroxylysine glucosidase: Three crucial carboxyl residues were determined by cloning and site-directed mutagenesis. , 2016, Biochemical and biophysical research communications.

[14]  Lixia Diao,et al.  Metastasis is regulated via microRNA-200/ZEB1 axis control of tumor cell PD-L1 expression and intratumoral immunosuppression , 2014, Nature Communications.

[15]  G. Christofori,et al.  The RNA-binding protein Rbfox2: an essential regulator of EMT-driven alternative splicing and a mediator of cellular invasion , 2014, Oncogene.

[16]  J. Tazi,et al.  MBNL1 and RBFOX2 cooperate to establish a splicing programme involved in pluripotent stem cell differentiation , 2013, Nature Communications.

[17]  M. Yamauchi,et al.  Lysine post-translational modifications of collagen. , 2012, Essays in biochemistry.

[18]  Nicholas C. Flytzanis,et al.  An EMT–Driven Alternative Splicing Program Occurs in Human Breast Cancer and Modulates Cellular Phenotype , 2011, PLoS genetics.

[19]  Mikala Egeblad,et al.  Matrix Crosslinking Forces Tumor Progression by Enhancing Integrin Signaling , 2009, Cell.

[20]  Alexander Pertsemlidis,et al.  Contextual extracellular cues promote tumor cell EMT and metastasis by regulating miR-200 family expression. , 2009, Genes & development.

[21]  M. Garcia-Blanco,et al.  TIA nuclear proteins regulate the alternate splicing of lysyl hydroxylase 2. , 2009, The Journal of investigative dermatology.

[22]  H. Cox,et al.  A connective tissue disorder caused by mutations of the lysyl hydroxylase 3 gene. , 2008, American journal of human genetics.

[23]  L. Meyaard.  The inhibitory collagen receptor LAIR‐1 (CD305) , 2008, Journal of leukocyte biology.

[24]  Chunguang Wang,et al.  Expanding the lysyl hydroxylase toolbox: New insights into the localization and activities of lysyl hydroxylase 3 (LH3) , 2007, Journal of cellular physiology.

[25]  M. Granato,et al.  The Myotomal diwanka (lh3) Glycosyltransferase and Type XVIII Collagen Are Critical for Motor Growth Cone Migration , 2006, Neuron.

[26]  D. Reid,et al.  Association of PLOD1 polymorphisms with bone mineral density in a population-based study of women from the UK , 2006, Osteoporosis International.

[27]  R. Bank,et al.  Phenotypic and molecular characterization of Bruck syndrome (osteogenesis imperfecta with contractures of the large joints) caused by a recessive mutation in PLOD2 , 2004, American journal of medical genetics. Part A.

[28]  E. Middelkoop,et al.  Increased formation of pyridinoline cross-links due to higher telopeptide lysyl hydroxylase levels is a general fibrotic phenomenon. , 2004, Matrix biology : journal of the International Society for Matrix Biology.

[29]  L. Ala‐Kokko,et al.  A homozygous stop codon in the lysyl hydroxylase gene in two siblings with Ehlers–Danlos syndrome type VI , 1992, Nature Genetics.

[30]  E. Beachey,et al.  Collagen-Induced Platelet Aggregation: Involvement of an Active Glycopeptide Fragment (α1-CB5) , 1973, Science.

[31]  M. Yamauchi,et al.  Lysine Hydroxylation and Cross-Linking of Collagen. , 2019, Methods in molecular biology.